C.M. Bidwell & Associates’s Sanofi SNY Stock Holding History

C.M. Bidwell & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,690	Closed	-$74K	–	457
2020 Q1	$74K	Buy	+1,690	New	+$80.9K	0.08%	189

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

C.M. Bidwell & Associates's SNY Position: Q2 2020 in Review

C.M. Bidwell & Associates sold out of Sanofi (SNY) in Q2 2020, closing a stake of 1,690 shares — an estimated $74K sold.

C.M. Bidwell & Associates first reported a position in SNY in Q1 2020 and held it in 1 quarter. The position peaked at $74K in Q1 2020. 582 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

C.M. Bidwell & Associates reported no remaining Sanofi position as of Q2 2020 after selling out during the quarter.
C.M. Bidwell & Associates sold 1,690 Sanofi shares in Q2 2020, an estimated $74K.
C.M. Bidwell & Associates first reported a position in Sanofi in Q1 2020 and held it in 1 quarter.
C.M. Bidwell & Associates's Sanofi position peaked at $74K in Q1 2020.
582 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2020, filed 14 Aug 2020.